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Muscular dystrophies are a heterogeneous group of genetic mus-
cle diseases characterized by progressive muscle weakness and
atrophy. Cardiomyopathy and congestive heart failure or con-
duction system abnormalities that cause arrhythmias, and sud-
den cardiac death have been observed in muscular dystrophies.
Despite the extensive research and ongoing clinical trials in mus-
cular dystrophy to improve skeletal muscle pathology and func-
tion, there is no effective treatment for this devastating disease.
Existence of an association between lethal arrhythmias and signs
of autonomic imbalance has initiated efforts to determine quan-
titative markers of autonomic activity in neuromuscular diseases.
To what extent unabated sympathetic overdrive contributes to
the eventual demise of skeletal and cardiac muscle remains to
be determined. These unexplored questions led us to compile
this research topic entitled “Autonomic Regulation in Muscular
Dystrophy” to help improve our understanding of the role of
autonomic nervous system in muscular dystrophy.
Angelini et al. in their overview have compiled together evi-
dence of aberrant autonomic signaling in a variety of clinically
defined muscular dystrophies (Angelini et al., 2013). Duchenne
(DMD) and Becker (BMD) muscular dystrophies are X-linked
recessive disorders due to complete or partial loss of the dys-
trophin protein. Tachycardia, atrial and ventricular arrhythmias,
sweating, and reduced heart rate variability (HRV) are com-
mon symptoms seen in DMD and BMD patients, even in the
absence of overt cardiomyopathy. These autonomic changes were
present early in the course of DMD/BMD and became more
marked with the progression of the disorder. In myotonic dystro-
phy 1 (MD1), caused by (CTG)n expansion in the gene encod-
ing dytrophia-myotonica-protein kinase (DMPK), orthostatic
hypotension, heart rhythm conduction disturbances, abnormal
gut movements, reduced HRV, and disorders of sweating are rela-
tively common. In their review, Angelini et al. have described that
increased sympathetic activity and an abnormal vasoconstric-
tor response are evident in other forms of muscular dystrophy
including Facio Scapulo Humeral muscular dystrophy (FSHD),
Emery-Dreifuss muscular dystrophy (EDMD), andMiyoshi mus-
cular dystrophy (MMD). In Fukuyama-type congenital muscu-
lar dystrophy (FCMD), decreased numbers of catecholaminergic
neurons in cardiovascular and respiratory centers of the brain has
been suggested as a cause of sudden death.
Whilst increased sympathetic activity and reduced parasym-
pathetic activity is now recognized as a hallmark of muscular
dystrophy, the mechanisms that contribute to this imbalance are
poorly understood. Smith and colleagues in their review dis-
cuss the possibility of the exercise pressor reflex as one such
mechanism that contributes to the autonomic imbalance in mus-
cular dystrophy. In muscular dystrophy, this reflex is possibly
exaggerated to cause an extreme activation of the sympathetic
nervous system during mild/moderate exercise. Exaggerated sym-
pathetic activation could restrain blood flow, arteriolar dilatation,
and capillary recruitment leading to under perfused areas of
the working dystrophic muscles. Exaggerated sympathetic acti-
vation would eventually increase the risk of developing myocar-
dial ischemia and cardiac arrest in muscular dystrophy patients
(Smith et al., 2014).
Dystrophin deficiency in DMD/BMD causes loss of muscle-
specific isoform of neuronal nitric oxide synthase (nNOSμ)
to reduce signaling of muscle-derived nitric oxide (NO).
Normally, during muscle contraction nNOSμ-derived NO dif-
fuses to the nearby microvessels to increase cGMP and
reduce norephineprine-mediated vasoconstriction. However, in
DMD/BMD lack of nNOSμ-derived NO causes unrestrained
sympathetic vasoconstriction and functional muscle ischemia
during exercise. As a consequence, the diseased muscles are prone
to injury during exercise in DMD/BMD. Strategies to improve
nNOSμ-NO signaling in dystrophic muscles as a promising ther-
apeutic intervention are discussed by Thomas (2013).
Review by Rudolf et al. provides evidence of altered cAMP-
signaling in skeletal muscles of humans and mdx mice with
muscular dystrophy. In the skeletal muscles, catecholamines pri-
marily stimulate β2-adrenergic receptors to regulate physiological
functions such as blood flow and metabolism. β2-adrenergic
receptors are G-protein-coupled receptors that couple to Gαs
to activate adenyl cyclase leading to an increase in cAMP. The
distribution of β2-adrenergic receptors is severely disturbed in
the dystrophic skeletal muscle. Therefore, improving the cAMP-
signaling in muscular dystrophy might be an effective approach
that needs to be investigated further (Rudolf et al., 2013).
Lastly, in the article by Sabharwal (2014), the link between
psychological stress disorders and autonomic dysfunction inmus-
cular dystrophy has been speculated. Due to social and physical
hardships patients with muscular dystrophy e.g., MD1, DMD,
and limb girdle muscular dystrophy (LGMD) may exhibit symp-
toms of psychological stress disorders such as anxiety and depres-
sion. Psychological stress is an independent predictor ofmortality.
In addition, there exists strong co-morbidity between cardiovas-
cular risk and stress disorders, such that presence of one increases
the likelihood of developing the other. Thus, it is logical to
speculate that autonomic dysfunction and psychological stress
synergistically exacerbate progression of muscular dystrophy, and
the potential mechanisms involved have been discussed. The
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renin angiotensin system (RAS) plays a vital role in cardiovascu-
lar homeostasis. RAS comprises of two axis namely, angiotensin II
(Ang II) that acts via type 1 and type 2 receptors, and angiotensin-
(1–7) acting via Mas receptors. While the sympathoexcitatory,
profibrotic, vasoconstrictor, and stress-inducing effects of Ang
II are widely recognized in many diseases, it is now becoming
evident that Ang-(1–7) is an important peptide that can counter-
regulate these actions. I have discussed how RAS peptides and
selective serotonin reuptake inhibitors can improve autonomic
function and reduce psychological stress in muscular dystrophy.
The articles included in this research topic highlight mech-
anisms that contribute to autonomic dysfunction in muscular
dystrophy. Furthermore, these articles will not only stimulate
further research but also encourage use of new strategies for
improving clinical outcomes in muscular dystrophy.
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